Zobrazeno 1 - 10
of 205
pro vyhledávání: '"Golemis, E."'
Autor:
Judd, J., Gandhi, N., Xiu, J., Deneka, A., Khan, H., Karim, N.A., Liu, S.V., Naqash, A.R., Borghaei, H., Golemis, E., Hemenway, G.
Publikováno v:
In Journal of Thoracic Oncology October 2024 19(10) Supplement:S168-S169
Publikováno v:
SCOPUS03005127-2017-45-1-SID85014882833
© 2017 The Author(s).Overexpression of the Aurora kinase A (AURKA) is oncogenic in many tumors. Many studies of AURKA have focused on activities of this kinase in mitosis, and elucidated the mechanisms by which AURKA activity is induced at the G2/M
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::1c5d9b42b11e390a06148ac9adba2aeb
https://openrepository.ru/article?id=719878
https://openrepository.ru/article?id=719878
Publikováno v:
SCOPUS-2017-12-4-SID85018265690
© 2017 Deneka et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are cr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::2a9096993905b01a1e665bbf7d91ee62
https://dspace.kpfu.ru/xmlui/handle/net/145284
https://dspace.kpfu.ru/xmlui/handle/net/145284
Autor:
Gaponova A., Deneka A., Beck T., Liu H., Andrianov G., Nikonova A., Nicolas E., Einarson M., Golemis E., Serebriiskii I.
Publikováno v:
SCOPUS-2017-8-12-SID85015725213
Ovarian, head and neck, and other cancers are commonly treated with cisplatin and other DNA damaging cytotoxic agents. Altered DNA damage response (DDR) contributes to resistance of these tumors to chemotherapies, some targeted therapies, and radiati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::9abf6f58b3b3aaf45015064b6093c2ff
https://openrepository.ru/article?id=61318
https://openrepository.ru/article?id=61318
Autor:
Beck T., Korobeynikov V., Kudinov A., Georgopoulos R., Solanki N., Andrews-Hoke M., Kistner T., Pépin D., Donahoe P., Nicolas E., Einarson M., Zhou Y., Boumber Y., Proia D., Serebriiskii I., Golemis E.
Publikováno v:
SCOPUS-2016-16-3-SID84989887233
© 2016 The Author(s)Anti-Müllerian hormone (AMH) and its type II receptor AMHR2, both previously thought to primarily function in gonadal tissue, were unexpectedly identified as potent regulators of transforming growth factor (TGF-β)/bone morphoge
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::2137bf3d1c8a821e63f2532f6a008081
https://openrepository.ru/article?id=687413
https://openrepository.ru/article?id=687413
Autor:
Beck T., Georgopoulos R., Shagisultanova E., Sarcu D., Handorf E., Dubyk C., Lango M., Ridge J., Astsaturov I., Serebriiskii I., Burtness B., Mehra R., Golemis E.
Publikováno v:
SCOPUS15357163-2016-15-10-SID84990985902
© 2016 American Association for Cancer Research.Clinical decision making for human papillomavirus (HPV)-negative head and neck squamous cell carcinoma (HNSCC) is predominantly guided by disease stage and anatomic location, with few validated biomark
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::0fa2bb214bb36a1670720cf9591def51
https://openrepository.ru/article?id=222429
https://openrepository.ru/article?id=222429
Autor:
Beglyarova N., Banina E., Zhou Y., Mukhamadeeva R., Andrianov G., Bobrov E., Lysenko E., Skobeleva N., Gabitova L., Restifo D., Pressman M., Serebriiskii I., Hoffman J., Paz K., Behrens D., Khazak V., Jablonski S., Golemis E., Weiner L., Astsaturov I.
Publikováno v:
SCOPUS10780432-2016-22-24-SID85006985653
©2016 AACR.Purpose: Even when diagnosed prior to metastasis, pancreatic ductal adenocarcinoma (PDAC) is a devastating malignancy with almost 90% lethality, emphasizing the need for new therapies optimally targeting the tumors of individual patients.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::7a24c70a0a33fda419bb95f0464b9e62
https://openrepository.ru/article?id=222153
https://openrepository.ru/article?id=222153
Autor:
Gaponova A., Nikonova A., Deneka A., Kopp M., Kudinov A., Skobeleva N., Khazak V., Ogawa L., Cai K., Duncan K., Duncan J., Egleston B., Proia D., Boumber Y., Golemis E.
Publikováno v:
SCOPUS10780432-2016-22-20-SID84991577399
©2016 AACR.Purpose: Small cell lung cancer (SCLC) is a highly aggressive disease representing 12% to 13% of total lung cancers, with median survival of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::01cc65379b1b5a23f61d5ee3a5f3093a
https://openrepository.ru/article?id=222152
https://openrepository.ru/article?id=222152
Autor:
Zhang Y., Nasto R., Varghese R., Jablonski S., Serebriiskii I., Surana R., Calvert V., Bebu I., Murray J., Jin L., Johnson M., Riggins R., Ressom H., Petricoin E., Clarke R., Golemis E., Weiner L.
Publikováno v:
SCOPUS09509232-2016-35-13-SID84949965535
© 2016 Macmillan Publishers Limited.Resistance to therapies targeting the estrogen pathway remains a challenge in the treatment of estrogen receptor-positive breast cancer. To address this challenge, a systems biology approach was used. A library of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::84f31dde5f5833c0d164d9628cc472f5
https://openrepository.ru/article?id=678404
https://openrepository.ru/article?id=678404
Autor:
Nicolas E., Arora S., Zhou Y., Serebriiskii I., Andrake M., Handorf E., Bodian D., Vockley J., Dunbrack R., Ross E., Egleston B., Hall M., Golemis E., Giri V., Daly M.
Publikováno v:
SCOPUS-2015-6-37-SID84950104313
Risk assessment for prostate cancer is challenging due to its genetic heterogeneity. In this study, our goal was to develop an operational framework to select and evaluate gene variants that may contribute to familial prostate cancer risk. Drawing on
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::18c282f92b33395ce9b0dab8070ca76e
https://dspace.kpfu.ru/xmlui/handle/net/141701
https://dspace.kpfu.ru/xmlui/handle/net/141701